Fecal microbiota transplantation in critically ill patients with feeding intolerance: a single-arm, open-label, prospective, exploratory study
This is a single-arm, open-label, prospective, exploratory study investigating the efficacy and safety of fecal microbiota transplantation (FMT) in critically ill patients with feeding intolerance. Gut microbiota profiles were analyzed using 16S rRNA gene sequencing to evaluate microbial changes associated with FMT treatment. The aim of this study is to explore the potential role of gut microbiota modulation in improving feeding intolerance and clinical outcomes in critically ill patients.